ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts16161717
Avg. Estimate-1.27-1.36-5.2-5.3
Low Estimate-1.64-1.62-5.87-7.11
High Estimate-0.78-1.1-4.67-1.99
Year Ago EPS-1.21-1.32-4.79-5.2
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts16161918
Avg. Estimate24.65M20.66M78.6M124.97M
Low Estimate15.93M12M56.59M3M
High Estimate64.58M37M121.84M394M
Year Ago Sales13.65M17.45M47.16M78.6M
Sales Growth (year/est)80.60%18.40%66.70%59.00%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-1.14-1.34-1.26-1.22
EPS Actual-1.21-1.32-1.25-1.34
Difference-0.070.020.01-0.12
Surprise %-6.10%1.50%0.80%-9.80%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-1.27-1.36-5.2-5.3
7 Days Ago-1.27-1.36-5.2-5.3
30 Days Ago-1.25-1.34-5.18-5.23
60 Days Ago-1.26-1.37-5.21-5.26
90 Days Ago-1.3-1.38-5.24-4.96
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A9
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesALNYIndustrySectorS&P 500
Current Qtr.-5.00%N/AN/A0.15
Next Qtr.-3.00%N/AN/A0.27
Current Year-8.60%N/AN/A0.07
Next Year-1.90%N/AN/A0.12
Next 5 Years (per annum)46.09%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A